je.st
news
Tag: inhibitor
Kao Patents Sotolone Odor Inhibitor
2016-04-01 22:58:00| Happi Breaking News
Tags: patents
inhibitor
kao
odor
Kao Patents Sotolone Odor Inhibitor
2016-04-01 22:54:00| Happi Breaking News
Tags: patents
inhibitor
kao
odor
Pfizer Announces FDA Approval Of XELJANZ XR (tofacitinib citrate) Extended-Release Tablets, The First And Only Once-Daily Oral JAK Inhibitor Treatment For Rheumatoid Arthritis
2016-03-02 04:30:55| drugdiscoveryonline Home Page
Pfizer Inc. announced recently that the U.S. Food and Drug Administration (FDA) has approved XELJANZ XR (tofacitinib citrate) extended-release 11 mg tablets for the once-daily treatment of moderate to severe rheumatoid arthritis (RA) in patients who have had an inadequate response or intolerance to methotrexate (MTX)
Tags: treatment
approval
oral
announces
Rust Inhibitor features solvent-free formula.
2016-02-25 14:31:05| Industrial Newsroom - All News for Today
Providing industrial strength rust protection and lubrication without harshness of chemicals, HinderRUST is safe for environment. Product requires minimal surface preparation and covers in single coat. HinderRUST performs for sustained periods of time, bonding to metal surfaces, stopping or preventing corrosion, and providing silky slick lubrication that won't get tacky. Typical applications include machine ways, bearings, hinges, joints, molding dies, and motors.
Tags: features
formula
rust
inhibitor
MARIZEV (Omarigliptin), Mercks Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes, Approved in Japan
2015-09-28 13:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved MARIZEV (omarigliptin) 25 mg and 12.5 mg tablets, an oral, once-weekly DPP-4 inhibitor indicated for the treatment of adults with type 2 diabetes. Japan is the first country to have approved omarigliptin. Language: English Contact: Media Contacts:Pam Eisele, 267-305-3558orMichael Close, 310-617-1067orKristen Drake, 908-236-4223orInvestor Contacts:Justin Holko, 908-740-1879orTeri Loxam, 908-740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more